Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma

International Journal of Cancer

Volumn 128, Issue 8, 2011, Pages 1852-1859

  Graveland, A Peggy ^a   Golusinski, Pawel J ^a,b,c   Buijze, Marijke ^a   Douma, Rinze ^a   Sons, Nanet ^a   Kuik, Dirk J ^a   Bloemena, Elisabeth ^a,d   Leemans, C René ^a   Brakenhoff, Ruud H ^a   Braakhuis, Boudewijn J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Poznan City Hospital   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

cancer progression; head and neck cancer; local relapse; LOH; p53; preneoplastic field

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ADULT; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER TISSUE; CHROMOSOME 17P; CHROMOSOME 3P; CHROMOSOME 9P; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; FEMALE; HEAD AND NECK CARCINOMA; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 9; DNA, NEOPLASM; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79951964986     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25523     Document Type: Article

References (42)

1. Lippman SM, Hong WK,. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 1989; 17: 691-4.
2. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB,. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 1994; 73: 187-90. (Pubitemid 24012742)
3. Braakhuis BJM, Tabor MP, Leemans CR, van der Waal, I, Snow GB, Brakenhoff RH,. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 2002; 24: 198-206. (Pubitemid 34111517)
4. Jovanovic A, van der Tol, I, Kostense PJ, Schulten EA, de Vries N, Snow GB, van der Waal I,. Second respiratory and upper digestive tract cancer following oral squamous cell carcinoma. Eur J Cancer B Oral Oncol 1994; 30B: 225-9. (Pubitemid 24257730)
5. Ha PK, Chang SS, Glazer CA, Califano JA, Sidransky D,. Molecular techniques and genetic alterations in head and neck cancer. Oral Oncol 2009; 45: 335-9.
6. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D,. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56: 2488-92. (Pubitemid 26170679)
7. Braakhuis BJM, Leemans CR, Brakenhoff RH,. A genetic progression model of oral cancer: current evidence and clinical implications. J Oral Pathol Med 2004; 33: 317-22. (Pubitemid 38931752)
8. Tabor MP, Brakenhoff RH, van Houten VMM, Kummer JA, Snel MH, Snijders PJ, Snow GB, Leemans CR, Braakhuis BJM,. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 2001; 7: 1523-32. (Pubitemid 32708615)
9. Roblyer D, Kurachi C, Stepanek V, Williams MD, El-Naggar AK, Lee JJ, Gillenwater AM, Richards-Kortum R,. Objective detection and delineation of oral neoplasia using autofluorescence imaging. Cancer Prev Res (Phila Pa) 2009; 2: 423-31.
10. Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, MacAulay C, Rosin MP,. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck 2007; 29: 71-6. (Pubitemid 46032570)
11. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, Correo R, Eby YJ, Ruppert JM, Sidransky D,. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993; 53: 4477-80. (Pubitemid 23304366)
12. Waridel F, Estreicher A, Bron L, Flaman JM, Fontolliet C, Monnier P, Frebourg T, Iggo R,. Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract. Oncogene 1997; 14: 163-9. (Pubitemid 27068302)
13. Tabor MP, van Houten VMM, Kummer JA, Vosjan MJ, Vlasblom R, Snow GB, Leemans CR, Braakhuis BJM, Brakenhoff RH,. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene. Genes Chromosomes Cancer 2002; 33: 168-77. (Pubitemid 34052498)
14. Cruz I, Napier SS, van der Waal I, Snijders PJ, Walboomers JM, Lamey PJ, Cowan CG, Gregg TA, Maxwell P, Meijer CJ,. Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. J Clin Pathol 2002; 55: 98-104. (Pubitemid 34123908)
15. van Houten VMM, Tabor MP, van den Brekel MW, Kummer JA, Denkers F, Dijkstra J, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH,. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol 2002; 198: 476-86. (Pubitemid 35447001)
16. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Kummer JA, Leemans CR, Braakhuis BJM,. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res 2004; 10: 3607-13. (Pubitemid 38697593)
17. Braakhuis BJM, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH,. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63: 1727-30. (Pubitemid 36460827)
18. Ha PK, Califano JA,. The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med 2003; 14: 363-9. (Pubitemid 44560790)
19. Nathan CO, Sanders K, Abreo FW, Nassar R, Glass J,. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications. Cancer Res 2000; 60: 3599-604. (Pubitemid 30482182)
20. Partridge M, Li SR, Pateromichelakis S, Francis R, Phillips E, Huang XH, Tesfa-Selase F, Langdon JD,. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res 2000; 6: 2718-25. (Pubitemid 30482110)
21. Sardi I, Franchi A, Ferriero G, Frittelli A, Bruschini L, Montali E, Gallo O,. Prediction of recurrence by microsatellite analysis in head and neck cancer. Genes Chromosomes Cancer 2000; 29: 201-6.
22. van der Toorn PP, Veltman JA, Bot FJ, de Jong JM, Manni JJ, Ramaekers FC, Hopman AH,. Mapping of resection margins of oral cancer for p53 overexpression and chromosome instability to detect residual (pre)malignant cells. J Pathol 2001; 193: 66-72. (Pubitemid 32051114)
23. Temam S, Casiraghi O, Lahaye JB, Bosq J, Zhou X, Julieron M, Mamelle G, Lee JJ, Mao L, Luboinski B, Benard J, Janot F,. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma. Clin Cancer Res 2004; 10: 4022-8. (Pubitemid 38812477)
24. Braakhuis BJM, Brakenhoff RH, Leemans CR,. Second field tumors: a new opportunity for cancer prevention? Oncologist 2005; 10: 493-500. (Pubitemid 41266330)
25. Lumerman H, Freedman P, Kerpel S,. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 321-9.
26. Tabor MP, Braakhuis BJM, van der Wal JE, van Diest PJ, Leemans CR, Brakenhoff RH, Kummer JA,. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx. J Pathol 2003; 199: 354-60. (Pubitemid 36266858)
27. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E,. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 2008; 37: 127-33. (Pubitemid 351178405)
28. Schepman KP, van der Meij EH, Smeele LE, van der Waal I,. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 1998; 34: 270-5. (Pubitemid 28318253)
29. Shanmugaratnam K, Sobin LH,. The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition. Cancer 1993; 71: 2689-97. (Pubitemid 23100513)
30. Gale N, Kambic V, Michaels L, Cardesa A, Hellquist H, Zidar N, Poljak M,. The Ljubljana classification: a practical strategy for the diagnosis of laryngeal precancerous lesions. Adv Anat Pathol 2000; 7: 240-51.
31. Bremmer JF, Braakhuis BJM, Ruijter-Schippers HJ, Brink A, Duarte HM, Kuik DJ, Bloemena E, Leemans CR, van der Waal I, Brakenhoff RH,. A noninvasive genetic screening test to detect oral preneoplastic lesions. Lab Invest 2005; 85: 1481-8. (Pubitemid 41662333)
32. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, van der Wal JE, Snow GB, Leemans CR, Braakhuis BJM,. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 2002; 161: 1051-60. (Pubitemid 34988393)
33. Cruz IB, Snijders PJ, Meijer CJ, Braakhuis BJM, Snow GB, Walboomers JM, van der Waal I,. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 1998; 184: 360-8.
34. Shah NG, Trivedi TI, Tankshali RA, Goswami JV, Jetly DH, Shukla SN, Shah PM, Verma RJ,. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck 2009; 31: 1544-56.
35. Rosin MP, Lam WL, Poh C, Le ND, Li RJ, Zeng T, Priddy R, Zhang L,. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res 2002; 62: 6447-50. (Pubitemid 35364104)
36. Partridge M, Pateromichelakis S, Phillips E, Emilion GG, A'Hern RP, Langdon JD,. A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res 2000; 60: 3893-8. (Pubitemid 32204583)
37. Mao L, Lee JS, Fan YH, Ro JY, Batsakis JG, Lippman S, Hittelman W, Hong WK,. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 1996; 2: 682-5. (Pubitemid 26191956)
38. Partridge M, Emilion G, Pateromichelakis S, A'Hern R, Phillips E, Langdon J,. Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer. Oral Oncol 1998; 34: 77-83. (Pubitemid 28207005)
39. Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, Berean K, Epstein JB, Priddy R, Le ND, Zhang L,. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000; 6: 357-62. (Pubitemid 30111451)
40. Huang X, Pateromichelakis S, Hills A, Sherriff M, Lyons A, Langdon J, Odell E, Morgan P, Harrison J, Partridge M,. p53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins. Clin Cancer Res 2007; 13: 6099-106. (Pubitemid 350075068)
41. Bergshoeff VE, Hopman AH, Zwijnenberg IR, Ramaekers FC, Bot FJ, Kremer B, Manni JJ, Speel EJ,. Chromosome instability in resection margins predicts recurrence of oral squamous cell carcinoma. J Pathol 2008; 215: 347-8. (Pubitemid 351956716)
42. Schaaij-Visser TB, Graveland AP, Gauci S, Braakhuis BJM, Buijze M, Heck AJ, Kuik DJ, Bloemena E, Leemans CR, Slijper M, Brakenhoff RH,. Differential proteomics identifies protein biomarkers that predict local relapse of head and neck squamous cell carcinomas. Clin Cancer Res 2009; 15: 7666-75.